Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03263117Phase 4Completed
A Phase 4 trial of lidocaine + fentanyl + propofol + rocuronium in ischemic stroke, sponsored by UTHealth Houston. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03263117.